semaglutide 1.7 Wegovy (semaglutide) Injector mg/0.75 mL, 4 Pens Per Box **Refrige — Mountainside Medical 1.7 mg semaglutide Noveltreat 1.7mg

A medication called tirzepatide , marketed under the brand name Mounjaro

Possible concerns for older adults include: loss of bone or muscle mass (or both) if weight loss is too rapid or not paired with resistance exercise (also called strength training) nutrient deficiencies if their appetite decreases without balancing nutrition, which can worsen existing vitamin B12, vitamin D, and protein deficiencies dehydration, dizziness, or digestive system side effects (such as diarrhea), which may cause new or worsened health problems hypoglycemia (low blood sugar) or hypotension (low blood pressure), which can affect people already taking medications for these conditions increased heart rate or increased blood pressure, which may carry a higher risk in older adults who have heart disease or take heart medications Glucagon-like peptide-1 (GLP-1) receptor agonists are prescription drugs used for weight management and other conditions

The medication has been known to have potential benefits for weight loss in some patients, although it is important to note that Ozempic is not specifically approved by the FDA for medical weight loss

This dehydration can also increase the risk of kidney injury, especially in those with pre-existing kidney conditions

If fatigue worsens or persists beyond six weeks on semaglutide, inform your provider immediately, as it may indicate a separate condition requiring investigation

Research shows that tirzepatide tends to produce greater weight loss (up to 15% weight loss with tirzepatide vs